Note: Ingredients listed on restricted chemical lists
EC/CAS
203-625-9/108-88-3
Name of the chemical
Toluene
Concentration
1 - 5
EC/CAS
209-136-7/556-67-2
Name of the chemical
D4
Concentration
<0,1
General Information
Version
2.0
Revision date
2023-05-03
Product name
SILISOL 73
1.2.1 Relevant identified uses
Professional use
Emergency telephone
+32(0)52/45.60.11, +32 70 245 245
Icons in SDS
Company Information
company name
CRC Industries Europe B.V
e-mail address of the competent person responsible for the Safety Data Sheet
hse@crcind.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H225, H361
Hazard statements
Code
Statements
H225
Highly Flammable liquid and vapour
Section 2
SECTION 2: Hazards identification
Adverse physicochemical, human health and environmental effects
Suspected of damaging fertility or the unborn child.
2.2 Label elements
Labelling
Hazard pictograms
GHS02 GHS08
Signal word
Danger
Contains
toluene
Hazard statements
H225 - Highly flammable liquid and vapour. H361 - Suspected of damaging the unborn child..
Precautionary statements
P102 - Keep out of reach of children. P201 - Obtain special instructions before use. P210 - Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking. P261 - Avoid breathing vapours/spray. P280 - Wear protective gloves/protective clothing/eye protection/face protection. P370+P378 - In case of fire: Use foam, carbon dioxide (CO2), dry sand, extinguishing powder to extinguish. P405 - Store locked up. P501 - Dispose of contents/container to a hazardous or special waste collection point, in accordance with local, regional, national and/or international regulation.
2.3 Other hazards
Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII
Further information
The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %. Component octamethylcyclotetrasiloxane; [D4] (556-67-2) This substance meets the PBT criteria of REACH regulation, annex XIII This substance meets the vPvB criteria of REACH regulation, annex XIII Component octamethylcyclotetrasiloxane; [D4](556-67-2) The substance is not included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605
